Bleeding and Clotting of COVID-19 Coagulopathy: Should We Anticoagulate?
This webinar will address the issue of COVID-19 and coagulopathy. The possible mechanisms for COVID-19 coagulopathy, along with the use of various types of testing including D-dimer and TEG/ROTEM to help predict the probability of clotting or bleeding in this population will be discussed, as well as the issues of therapeutic and prophylactic anticoagulation and when it may be indicated in certain patient populations. Live Q&A to follow. Webinar is supported by Sanofi US.